Designed for the pharmaceutical and packaging markets, the Braillejet uses UV-cured ink allowing micro valves, which are similar to inkjet technology, to produce the Braille's raised bumps.

It is designed to offer an alternative and lower cost technique for producing Braille for run lengths that would be too expensive to set up using conventional techniques such as screen print and flexo.

The Braillejet printhead is able to print two lines of text at a time, and multiple heads can be stitched together to cover a wider area.

UV inks are cured with an innovative LED-based low energy lamp. Additional features include full inspection and verification.

Braillejet is one of three new machines being launched at Drupa, along with the Omega 210 digital industrial inkjet printer and the Flexojet 600 – a modular system for UV printing.